Metrics fatigue

› Forums › General Melanoma Community › Metrics fatigue

  • Post
    • September 26, 2016 at 6:13 am
    Wbatz
    Participant
      I had melanoma removed from my right foot, lymph nodes from my right thigh. I’m on my 5th dose of lectures and so sore and exhausted, I can barely get through a day. I used to play several sports, that’s over with for now. Has metrics had this effect on anyone else?

      Thanks

    Viewing 5 reply threads
    • Replies
        • September 26, 2016 at 7:09 am
        Wbatz
        Participant

          Keytruda fatigue

           

          For some reason my lousy spell-check doesnt like the word keytruda

           

          • September 26, 2016 at 7:09 am
          Wbatz
          Participant

            Keytruda fatigue

             

            For some reason my lousy spell-check doesnt like the word keytruda

             

            • September 26, 2016 at 7:09 am
            Wbatz
            Participant

              Keytruda fatigue

               

              For some reason my lousy spell-check doesnt like the word keytruda

               

              • September 26, 2016 at 2:04 pm
              Bubbles
              Participant

                Sorry for your fatigue and auto-correct! Fatigue is a very common side effect to anti-PD1, no matter if you are taking pembrolizumab (keytruda) or nivolizumab (opdivo). Some folks I have known actually had to go on disability whioe others felt really tired but managed to keep some semblance of their reguoar schedule. I blogged through my 2 1/2 years on Opdivo, often noting that I felt like "something the cat (or more accurately my large dog!) dragged in"! However, I continued my work schedule and running (despite some days of a rather sad performance). 

                Here is a post I put together some time ago if you are interested: http://chaoticallypreciselifeloveandmelanoma.blogspot.fr/2014

                I wish you well. Celeste

                  • September 27, 2016 at 4:21 am
                  Wbatz
                  Participant

                    Hi.Thanks for your response. I'm glad you were able to keep running. I'm still working, but my hockey career is probably over. Sometimes I seem unable to do the smallest things. I'll be reading your blog, but it will have to wait a bit (I'm at work….shhh)Thanks again for you response and your blog. It's always helpful to read how someone else handles it.

                    • September 27, 2016 at 4:21 am
                    Wbatz
                    Participant

                      Hi.Thanks for your response. I'm glad you were able to keep running. I'm still working, but my hockey career is probably over. Sometimes I seem unable to do the smallest things. I'll be reading your blog, but it will have to wait a bit (I'm at work….shhh)Thanks again for you response and your blog. It's always helpful to read how someone else handles it.

                      • September 27, 2016 at 4:21 am
                      Wbatz
                      Participant

                        Hi.Thanks for your response. I'm glad you were able to keep running. I'm still working, but my hockey career is probably over. Sometimes I seem unable to do the smallest things. I'll be reading your blog, but it will have to wait a bit (I'm at work….shhh)Thanks again for you response and your blog. It's always helpful to read how someone else handles it.

                      • September 26, 2016 at 2:04 pm
                      Bubbles
                      Participant

                        Sorry for your fatigue and auto-correct! Fatigue is a very common side effect to anti-PD1, no matter if you are taking pembrolizumab (keytruda) or nivolizumab (opdivo). Some folks I have known actually had to go on disability whioe others felt really tired but managed to keep some semblance of their reguoar schedule. I blogged through my 2 1/2 years on Opdivo, often noting that I felt like "something the cat (or more accurately my large dog!) dragged in"! However, I continued my work schedule and running (despite some days of a rather sad performance). 

                        Here is a post I put together some time ago if you are interested: http://chaoticallypreciselifeloveandmelanoma.blogspot.fr/2014

                        I wish you well. Celeste

                        • September 26, 2016 at 2:04 pm
                        Bubbles
                        Participant

                          Sorry for your fatigue and auto-correct! Fatigue is a very common side effect to anti-PD1, no matter if you are taking pembrolizumab (keytruda) or nivolizumab (opdivo). Some folks I have known actually had to go on disability whioe others felt really tired but managed to keep some semblance of their reguoar schedule. I blogged through my 2 1/2 years on Opdivo, often noting that I felt like "something the cat (or more accurately my large dog!) dragged in"! However, I continued my work schedule and running (despite some days of a rather sad performance). 

                          Here is a post I put together some time ago if you are interested: http://chaoticallypreciselifeloveandmelanoma.blogspot.fr/2014

                          I wish you well. Celeste

                      Viewing 5 reply threads
                      • You must be logged in to reply to this topic.
                      About the MRF Patient Forum

                      The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                      The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.